Kidney Function » Clinical Nephrology http://kidneyfunction.org Renal Information Sun, 22 Jan 2012 23:48:20 +0000 en hourly 1 http://wordpress.org/?v=3.0.2 Successful antibiotic lock therapy in patients with refractory peritonitis. http://kidneyfunction.org/successful-antibiotic-lock-therapy-in-patients-with-refractory-peritonitis/ http://kidneyfunction.org/successful-antibiotic-lock-therapy-in-patients-with-refractory-peritonitis/#comments Mon, 30 Nov 2009 23:00:00 +0000 Clinical Nephrology http://3053566 This study suggests that antibiotic lock therapy in the treatment of refractory peritonitis can be an effective method without catheter removal.
PMID: 19954727 [PubMed - in process] (Source: Clinical Nephrology)

]]> http://kidneyfunction.org/successful-antibiotic-lock-therapy-in-patients-with-refractory-peritonitis/feed/ 0 Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis. http://kidneyfunction.org/pharmacokinetics-of-rosuvastatin-in-patients-with-end-stage-kidney-disease-undergoing-peritoneal-dialysis/ http://kidneyfunction.org/pharmacokinetics-of-rosuvastatin-in-patients-with-end-stage-kidney-disease-undergoing-peritoneal-dialysis/#comments Mon, 30 Nov 2009 23:00:00 +0000 Clinical Nephrology http://3053573 Authors: Bologa R, Levine D, Parker T, Gordon B, Lanto A, Cheigh J, Stenzel K, Rubin A,
Patients undergoing dialysis treatment have a high incidence of dyslipidemia. Rosuvastatin is a potent statin drug that improves overall lipid profiles in dyslipidemic patients. However, the pharmacokinetics of rosuvastatin has not been studied in patients with end-stage kidney disease undergoing chronic peritoneal dialysis (PD). The goals of this study are to determine the pharmacokinetics and tolerability of a single oral dose of rosuvastatin in patients undergoing continuous ambulatory PD (CAPD). This was a nonrandomized, open-label, 1-week trial. Ten stable PD patients were given a single oral dose of rosuvastatin (10 mg). Serial blood samples were obtained over the next 48 hours, and the patie…

]]> http://kidneyfunction.org/pharmacokinetics-of-rosuvastatin-in-patients-with-end-stage-kidney-disease-undergoing-peritoneal-dialysis/feed/ 0 Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels. http://kidneyfunction.org/raloxifene-ameliorates-progressive-bone-loss-in-postmenopausal-dialysis-patients-with-controlled-parathyroid-hormone-levels/ http://kidneyfunction.org/raloxifene-ameliorates-progressive-bone-loss-in-postmenopausal-dialysis-patients-with-controlled-parathyroid-hormone-levels/#comments Mon, 30 Nov 2009 23:00:00 +0000 Clinical Nephrology http://3053575

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

]]> Conclusions: Raloxifene treatment was useful for the prevention of BMD deterioration in postmenopausal dialysis patients with controlled iPTH levels.
PMID: 19954718 [PubMed - in process] (Source: Clinical Nephrology)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

]]> http://kidneyfunction.org/raloxifene-ameliorates-progressive-bone-loss-in-postmenopausal-dialysis-patients-with-controlled-parathyroid-hormone-levels/feed/ 0